Mark Belletrutti MD
banner
mbelletr.bsky.social
Mark Belletrutti MD
@mbelletr.bsky.social
#medsky #HemeSky #haemostasis #thrombosis #pediatrics Pediatric Hematologist in Vancouver 🇨🇦 All opinions are my own. Any medical advice should be discussed with your own doctor.
An excellent opportunity for sure as long as funding increases to do this. #science #Medsky
March 21, 2025 at 7:10 PM
Reposted by Mark Belletrutti MD
Learn more about the history of #women and #hemophilia: A narrative review of evolving beliefs and testing practices.

Read more here: www.jthjournal.org/article/S153...
March 19, 2025 at 3:39 PM
Reposted by Mark Belletrutti MD
RPTH Cares about Women's Health 🌸: NAID and IDA are extremely prevalent among women, largely due to iron losses from vaginal blood loss.
Explore the findings: www.rpthjournal.org/article/S247...
@isth.org
#IronDeficiency #WomensHealth
The detrimental impact of ferritin “normal” ranges on diagnosis of bleeding disorders in women
In this editorial, we use the term “women” to highlight the experiences of and care gaps for women with nonanemic iron deficiency (NAID) and iron deficiency anemia (IDA) and the term “females” in refe...
www.rpthjournal.org
March 17, 2025 at 7:00 PM
Reposted by Mark Belletrutti MD
It's time to rethink hemophilia A treatment! Join us on April 17 for a special #WorldHemophiliaDay @rpth.bsky.social Research Recap as we explore findings from the HAVEN 6 trial & discuss why treatment guidelines must evolve to reflect clinical needs: streamyard.com/watch/cY5iiQ...
Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trial
Join author Cedric Hermans on World Hemophilia Day as he discusses his recent RPTH article, "Extending health equity to people with moderate and mild hemophilia A: revisiting the HAVEN 6 trial" with m...
streamyard.com
March 19, 2025 at 2:52 PM